Related Articles
MicroRNA expression profiles in benign prostatic hyperplasia
Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues
Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules
Cytogenetic changes and loss of heterozygosity in atypical adenomatous hyperplasia, in carcinoma of the prostate and in non-neoplastic prostate tissue using comparative genomic hybridization and multiplex-PCR
MONOCLONAL-ANTIBODY PD-41 RECOGNIZES A PROSTATE-CANCER ASSOCIATED ANTIGEN WHOSE EXPRESSION INCREASES IN METASTASES AND FOLLOWING HORMONAL-THERAPY